New drug combination doubles survival for people with bladder cancer: Clinical trial

Results from a clinical trial carried out by researchers at Barts Health NHS Trust and Queen Mary University of London show that a new combination of drugs doubles overall survival for patients with bladder cancer that has spread (metastatic bladder cancer).

Leave A Comment

Your email address will not be published. Required fields are marked *